A Phase 1, First-in-Human, Dose Escalation and Expansion, Multicenter Study of XMT-1660 in Participants with Solid Tumors.

Phase I Clinical Trial

Trial Number: 05377996
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations